RETA Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-13 | Bir Dawn Carter | officer: Chief Commercial Officer | 32,196 | S-Sale | D | 9,317 | 86.77 | 808,436.09 |
| 2023-03-10 | Ruff Shamim | director | 1,405 | M-Exempt | D | 4,215 | 34.76 | 146,513.40 |
| 2023-03-10 | Ruff Shamim | director | 443 | M-Exempt | D | 1,326 | 34.76 | 46,091.76 |
| 2023-03-10 | Ruff Shamim | director | 0 | M-Exempt | D | 199 | 27.32 | 5,436.68 |
| 2023-03-10 | Ruff Shamim | director | 5,223 | S-Sale | D | 5,740 | 83.73 | 480,610.20 |
| 2023-03-10 | Ruff Shamim | director | 10,963 | M-Exempt | A | 4,215 | 34.76 | 146,513.40 |
| 2023-03-10 | Ruff Shamim | director | 6,748 | M-Exempt | A | 1,326 | 34.76 | 46,091.76 |
| 2023-03-10 | Ruff Shamim | director | 5,422 | M-Exempt | A | 199 | 27.32 | 5,436.68 |
| 2023-03-07 | Loewen Andrea | officer: SVP, Global Regulatory Affairs | 35,000 | M-Exempt | D | 15,000 | 27.32 | 409,800.00 |
| 2023-03-07 | Loewen Andrea | officer: SVP, Global Regulatory Affairs | 38,757 | S-Sale | D | 1,200 | 84.44 | 101,328.00 |
| 2023-03-07 | Loewen Andrea | officer: SVP, Global Regulatory Affairs | 39,957 | S-Sale | D | 17,836 | 83.36 | 1,486,808.96 |
| 2023-03-07 | Loewen Andrea | officer: SVP, Global Regulatory Affairs | 57,793 | M-Exempt | A | 15,000 | 27.32 | 409,800.00 |
| 2023-03-07 | Bir Dawn Carter | officer: Chief Commercial Officer | 0 | C-Conversion | D | 41,630 | 0.00 | 0.00 |
| 2023-03-07 | Bir Dawn Carter | officer: Chief Commercial Officer | 41,630 | M-Exempt | D | 41,630 | 21.05 | 876,311.50 |
| 2023-03-07 | Bir Dawn Carter | officer: Chief Commercial Officer | 0 | M-Exempt | D | 41,630 | 21.05 | 876,311.50 |
| 2023-03-07 | Bir Dawn Carter | officer: Chief Commercial Officer | 41,513 | S-Sale | D | 200 | 86.67 | 17,334.00 |
| 2023-03-07 | Bir Dawn Carter | officer: Chief Commercial Officer | 41,713 | S-Sale | D | 5,793 | 85.90 | 497,618.70 |
| 2023-03-07 | Bir Dawn Carter | officer: Chief Commercial Officer | 47,506 | S-Sale | D | 36,049 | 85.08 | 3,067,048.92 |
| 2023-03-07 | Bir Dawn Carter | officer: Chief Commercial Officer | 83,555 | C-Conversion | A | 41,630 | 0.00 | 0.00 |
| 2023-03-07 | Anand Bhaskar | officer: SVP, Chief Accounting Officer | 26,765 | S-Sale | D | 165 | 84.58 | 13,955.70 |
| 2023-03-07 | Meyer Colin John | officer: Chief Innovation Officer | 84,606 | S-Sale | D | 621 | 84.57 | 52,517.97 |
| 2023-03-07 | WORTLEY MICHAEL D | officer: Chief Legal Officer | 48,092 | S-Sale | D | 414 | 84.46 | 34,966.44 |
| 2023-03-07 | Soni Manmeet Singh | officer: COO, CFO and President | 88,304 | S-Sale | D | 622 | 84.70 | 52,680.29 |
| 2023-03-07 | Khan Samina | officer: SVP, Chief Medical Officer | 40,131 | S-Sale | D | 3,961 | 83.46 | 330,585.06 |
| 2023-03-06 | Bir Dawn Carter | officer: Chief Commercial Officer | 0 | C-Conversion | D | 48,370 | 0.00 | 0.00 |
| 2023-03-06 | Bir Dawn Carter | officer: Chief Commercial Officer | 48,370 | M-Exempt | D | 48,370 | 21.05 | 1,018,188.50 |
| 2023-03-06 | Bir Dawn Carter | officer: Chief Commercial Officer | 41,630 | M-Exempt | D | 48,370 | 21.05 | 1,018,188.50 |
| 2023-03-06 | Bir Dawn Carter | officer: Chief Commercial Officer | 41,925 | S-Sale | D | 14,820 | 90.26 | 1,337,653.20 |
| 2023-03-06 | Bir Dawn Carter | officer: Chief Commercial Officer | 56,745 | S-Sale | D | 40,134 | 89.30 | 3,583,966.20 |
| 2023-03-06 | Bir Dawn Carter | officer: Chief Commercial Officer | 96,879 | C-Conversion | A | 48,370 | 0.00 | 0.00 |
| 2023-03-03 | McGaughy R Kent Jr | director, 10 percent owner | 0 | G-Gift | D | 33,217 | 0.00 | 0.00 |
| 2023-03-03 | Meyer Colin John | officer: Chief Innovation Officer | 85,227 | S-Sale | D | 5,286 | 87.35 | 461,732.10 |
| 2023-03-03 | Soni Manmeet Singh | officer: COO, CFO and President | 88,926 | S-Sale | D | 3,587 | 87.97 | 315,548.39 |
| 2023-03-03 | WORTLEY MICHAEL D | officer: Chief Legal Officer | 48,506 | S-Sale | D | 2,169 | 87.57 | 189,939.33 |
| 2023-03-03 | Loewen Andrea | officer: SVP, Global Regulatory Affairs | 42,793 | S-Sale | D | 1,601 | 87.73 | 140,455.73 |
| 2023-03-03 | Khan Samina | officer: SVP, Chief Medical Officer | 44,092 | S-Sale | D | 2,813 | 87.36 | 245,743.68 |
| 2023-03-03 | Anand Bhaskar | officer: SVP, Chief Accounting Officer | 26,930 | S-Sale | D | 820 | 87.47 | 71,725.40 |
| 2023-03-03 | Bir Dawn Carter | officer: Chief Commercial Officer | 48,509 | S-Sale | D | 2,166 | 88.25 | 191,147.55 |
| 2023-03-02 | Meyer Colin John | officer: Chief Innovation Officer | 74,304 | C-Conversion | D | 88,636 | 0.00 | 0.00 |
| 2023-03-02 | Meyer Colin John | officer: Chief Innovation Officer | 162,940 | M-Exempt | D | 88,636 | 11.00 | 974,996.00 |
| 2023-03-02 | Meyer Colin John | officer: Chief Innovation Officer | 0 | M-Exempt | D | 88,636 | 11.00 | 974,996.00 |
| 2023-03-02 | Meyer Colin John | officer: Chief Innovation Officer | 90,513 | S-Sale | D | 810 | 90.58 | 73,369.80 |
| 2023-03-02 | Meyer Colin John | officer: Chief Innovation Officer | 91,323 | S-Sale | D | 11,181 | 88.50 | 989,518.50 |
| 2023-03-02 | Meyer Colin John | officer: Chief Innovation Officer | 102,504 | S-Sale | D | 19,099 | 87.55 | 1,672,117.45 |
| 2023-03-02 | Meyer Colin John | officer: Chief Innovation Officer | 121,603 | S-Sale | D | 34,794 | 86.49 | 3,009,333.06 |
| 2023-03-02 | Meyer Colin John | officer: Chief Innovation Officer | 156,397 | S-Sale | D | 22,752 | 85.23 | 1,939,152.96 |
| 2023-03-02 | Meyer Colin John | officer: Chief Innovation Officer | 179,149 | C-Conversion | A | 88,636 | 0.00 | 0.00 |
| 2023-03-02 | Loewen Andrea | officer: SVP, Global Regulatory Affairs | 44,394 | S-Sale | D | 218 | 90.61 | 19,752.98 |
| 2023-03-02 | Khan Samina | officer: SVP, Chief Medical Officer | 25,000 | M-Exempt | D | 25,000 | 27.32 | 683,000.00 |
| 2023-03-02 | Khan Samina | officer: SVP, Chief Medical Officer | 46,905 | S-Sale | D | 2,649 | 85.38 | 226,171.62 |
| 2023-03-02 | Khan Samina | officer: SVP, Chief Medical Officer | 49,554 | S-Sale | D | 18,956 | 85.02 | 1,611,639.12 |
| 2023-03-02 | Khan Samina | officer: SVP, Chief Medical Officer | 68,510 | S-Sale | D | 3,395 | 83.70 | 284,161.50 |
| 2023-03-02 | Khan Samina | officer: SVP, Chief Medical Officer | 71,905 | M-Exempt | A | 25,000 | 27.32 | 683,000.00 |
| 2023-03-02 | Huff James Warren | director, officer: Chief Executive Officer | 36,158 | S-Sale | D | 570 | 91.12 | 51,938.40 |
| 2023-03-02 | Huff James Warren | director, officer: Chief Executive Officer | 36,728 | S-Sale | D | 4,623 | 90.57 | 418,705.11 |
| 2023-03-02 | Huff James Warren | director, officer: Chief Executive Officer | 41,351 | S-Sale | D | 5,742 | 89.49 | 513,851.58 |
| 2023-03-02 | Huff James Warren | director, officer: Chief Executive Officer | 47,093 | S-Sale | D | 12,826 | 88.59 | 1,136,255.34 |
| 2023-03-02 | Huff James Warren | director, officer: Chief Executive Officer | 59,919 | S-Sale | D | 4,034 | 87.61 | 353,418.74 |
| 2023-03-02 | Huff James Warren | director, officer: Chief Executive Officer | 63,953 | S-Sale | D | 3,475 | 86.44 | 300,379.00 |
| 2023-03-02 | Huff James Warren | director, officer: Chief Executive Officer | 67,428 | S-Sale | D | 6,395 | 85.25 | 545,173.75 |
| 2023-03-02 | Huff James Warren | director, officer: Chief Executive Officer | 73,823 | S-Sale | D | 7,439 | 84.33 | 627,330.87 |
| 2023-03-02 | Huff James Warren | director, officer: Chief Executive Officer | 81,262 | S-Sale | D | 9,660 | 83.31 | 804,774.60 |
| 2023-03-02 | Huff James Warren | director, officer: Chief Executive Officer | 90,922 | S-Sale | D | 12,132 | 82.20 | 997,250.40 |
| 2023-03-02 | Huff James Warren | director, officer: Chief Executive Officer | 103,054 | S-Sale | D | 8,104 | 81.49 | 660,394.96 |
| 2023-03-01 | Huff James Warren | director, officer: Chief Executive Officer | 212,903 | C-Conversion | D | 75,000 | 0.00 | 0.00 |
| 2023-03-01 | Huff James Warren | director, officer: Chief Executive Officer | 111,158 | C-Conversion | A | 75,000 | 0.00 | 0.00 |
| 2023-03-01 | Anand Bhaskar | officer: SVP, Chief Accounting Officer | 6,000 | A-Award | A | 6,000 | 28.78 | 172,680.00 |
| 2023-03-01 | Anand Bhaskar | officer: SVP, Chief Accounting Officer | 27,750 | A-Award | A | 3,000 | 0.00 | 0.00 |
| 2023-02-28 | Meyer Colin John | officer: Chief Innovation Officer | 30,000 | A-Award | A | 30,000 | 27.32 | 819,600.00 |
| 2023-02-28 | Meyer Colin John | officer: Chief Innovation Officer | 90,513 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2023-02-28 | Soni Manmeet Singh | officer: COO, CFO and President | 75,000 | A-Award | A | 75,000 | 34.15 | 2,561,250.00 |
| 2023-01-03 | Huff James Warren | director, officer: Chief Executive Officer | 190,950 | A-Award | A | 190,950 | 36.71 | 7,009,774.50 |
| 2023-01-03 | Huff James Warren | director, officer: Chief Executive Officer | 47,025 | A-Award | A | 47,025 | 0.00 | 0.00 |
| 2023-01-03 | Soni Manmeet Singh | officer: COO, CFO and President | 95,475 | A-Award | A | 95,475 | 36.71 | 3,504,887.25 |
| 2023-01-03 | Soni Manmeet Singh | officer: COO, CFO and President | 92,513 | A-Award | A | 23,513 | 0.00 | 0.00 |
| 2023-01-03 | WORTLEY MICHAEL D | officer: Chief Legal Officer | 63,650 | A-Award | A | 63,650 | 36.71 | 2,336,591.50 |
| 2023-01-03 | WORTLEY MICHAEL D | officer: Chief Legal Officer | 50,675 | A-Award | A | 15,675 | 0.00 | 0.00 |
| 2023-01-03 | Meyer Colin John | officer: Chief Innovation Officer | 95,475 | A-Award | A | 95,475 | 36.71 | 3,504,887.25 |
| 2023-01-03 | Meyer Colin John | officer: Chief Innovation Officer | 75,513 | A-Award | A | 23,513 | 0.00 | 0.00 |
| 2023-01-03 | Khan Samina | officer: SVP, Chief Medical Officer | 47,738 | A-Award | A | 47,738 | 36.71 | 1,752,461.98 |
| 2023-01-03 | Khan Samina | officer: SVP, Chief Medical Officer | 46,905 | A-Award | A | 11,756 | 0.00 | 0.00 |
| 2023-01-03 | Loewen Andrea | officer: SVP, Global Regulatory Affairs | 47,738 | A-Award | A | 47,738 | 36.71 | 1,752,461.98 |
| 2023-01-03 | Loewen Andrea | officer: SVP, Global Regulatory Affairs | 44,612 | A-Award | A | 11,756 | 0.00 | 0.00 |
| 2023-01-03 | Anand Bhaskar | officer: VP, Chief Accounting Officer | 33,500 | A-Award | A | 33,500 | 36.71 | 1,229,785.00 |
| 2023-01-03 | Anand Bhaskar | officer: VP, Chief Accounting Officer | 24,750 | A-Award | A | 8,250 | 0.00 | 0.00 |
| 2023-01-03 | Bir Dawn Carter | officer: Chief Commercial Officer | 63,650 | A-Award | A | 63,650 | 36.71 | 2,336,591.50 |
| 2023-01-03 | Bir Dawn Carter | officer: Chief Commercial Officer | 50,675 | A-Award | A | 15,675 | 0.00 | 0.00 |
| 2022-07-11 | Ryder Steven | director | 5,492 | A-Award | A | 5,492 | 32.36 | 177,721.12 |
| 2022-07-11 | Ryder Steven | director | 6,038 | A-Award | A | 6,038 | 32.36 | 195,389.68 |
| 2022-07-11 | Ryder Steven | director | 1,322 | A-Award | A | 1,322 | 32.36 | 42,779.92 |
| 2022-07-11 | Ryder Steven | director | 8,878 | A-Award | A | 3,794 | 32.36 | 122,773.84 |
| 2022-07-11 | Ryder Steven | director | 5,084 | A-Award | A | 4,171 | 32.36 | 134,973.56 |
| 2022-07-11 | Ryder Steven | director | 913 | A-Award | A | 913 | 32.36 | 29,544.68 |
| 2022-06-08 | McGaughy R Kent Jr | director, 10 percent owner | 4,787 | A-Award | A | 4,787 | 34.76 | 166,396.12 |
| 2022-06-08 | McGaughy R Kent Jr | director, 10 percent owner | 11,240 | A-Award | A | 11,240 | 34.76 | 390,702.40 |
| 2022-06-08 | ROSE WILLIAM | other | 3,330 | A-Award | A | 3,330 | 34.76 | 115,750.80 |
| 2022-06-08 | ROSE WILLIAM | other | 11,240 | A-Award | A | 11,240 | 34.76 | 390,702.40 |
| 2022-06-08 | Ruff Shamim | director | 5,620 | A-Award | A | 5,620 | 34.76 | 195,351.20 |
| 2022-06-08 | Ruff Shamim | director | 1,769 | A-Award | A | 1,769 | 34.76 | 61,490.44 |
| 2022-06-08 | Ruff Shamim | director | 5,223 | A-Award | A | 3,883 | 34.76 | 134,973.08 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.